FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 3083418 · Received April 29, 2013

Report

Report Number
1416980-2013-10724
Event Type
Injury
Date Received
April 29, 2013
Date of Event
March 29, 2013
Report Date
April 5, 2013
Manufacturer
BAXTER HEALTHCARE
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VM
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). BAXTER HAS CONDUCTED A TREND REVIEW AND FOUND THAT SIMILAR REPORTS HAVE BEEN RECEIVED FOR THE REPORTED CONDITION. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED. SHOULD RELEVANT ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL INFORMATION: TWO DAYS AFTER USING ANTIBIOTICS, THE PATIENT RECOVERED FROM THE ABDOMINAL PAIN AND THE CLOUDY EFFLUENT. SIXTEEN DAYS AFTER HOSPITALIZATION, THE PATIENT HAD RECOVERED FROM THE PERITONITIS. THE FOLLOWING DAY, THE PATIENT STOPPED TREATMENT WITH ANTIBIOTICS AND WAS DISCHARGED FROM THE HOSPITAL. SHOULD RELEVANT ADDITIONAL INFORMATION BECOME AVAILABLE, A FOLLOW-UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT EXPERIENCED AND WAS HOSPITALIZED FOR PERITONITIS COINCIDENT WITH THERAPY FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD). THERAPY WAS ONGOING. PRIOR TO HOSPITALIZATION, THE PATIENT EXPERIENCED DIARRHEA, TENDERNESS, AND CLOUDY EFFLUENT. AS A RESULT OF THE PERITONITIS, THE PATIENT EXPERIENCED A FEVER. THE PATIENT WAS TREATED WITH VANCOMYCIN, GENTAMYCIN AND CEFAZOLIN FOR THE PERITONITIS. AT THE TIME OF THIS REPORT, THE PATIENT WAS RECOVERING FROM THE PERITONITIS. IT WAS UNKNOWN IF THE PATIENT RECOVERED FROM THE MUDDY FLUID, TENDERNESS, AND DIARRHEA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
184803 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R DIANEAL PD4 1.5%